Biotech · Private company
NeuroBo Pharmaceuticals Inc.
Track this companyFree. Adds NeuroBo Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- NiclosamidePhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- DA-1241Phase 2 · NON-ALCOHOLIC STEATOHEPATITISClinicalTrials.gov · fetched Nov 12, 2026
- DA-9801 300mgPhase 2 · Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- DA-9801 600mgPhase 2 · Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- DA-9801 900mgPhase 2 · Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- GemcabenePhase 2 · HypercholesteremiaClinicalTrials.gov · fetched Nov 12, 2026
- GemcabenePhase 2 · Severe HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- SitagliptinPhase 2 · NON-ALCOHOLIC STEATOHEPATITISClinicalTrials.gov · fetched Nov 12, 2026
- DA-1726Phase 1 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- NiclosamidePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- First in Human Study in Subjects With Obesity, But Otherwise HealthyPHASE1 · RECRUITING · started Mar 25, 2024ClinicalTrials.gov NCT06252220 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASHPHASE2 · COMPLETED · started Sep 14, 2023ClinicalTrials.gov NCT06054815 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study of Niclosamide in Healthy VolunteersPHASE1 · COMPLETED · started Nov 17, 2020ClinicalTrials.gov NCT04705415 · fetched Nov 12, 2026
- Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) PatientsPHASE2_PHASE3 · COMPLETED · started Oct 7, 2020ClinicalTrials.gov NCT04603924 · fetched Nov 12, 2026
- A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe HypertriglyceridemiaPHASE2 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02944383 · fetched Nov 12, 2026
- A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity StatinsPHASE2 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02634151 · fetched Nov 12, 2026
- Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)PHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02722408 · fetched Nov 12, 2026
- Study of DA-9801 to Treat Diabetic NeuropathyPHASE2 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT01822925 · fetched Nov 12, 2026